Source document or public record

FDA 510(k) K211199 — ST AIA-PACK BNP Assay

FDA 510(k) index record K211199. Device: ST AIA-PACK BNP Assay. Applicant as listed: Tosoh Bioscience, Inc.. Decision date: 2021-11-08.

OtherU.S. Food and Drug Administration (FDA)2021-11-08

Source

"device_name": "ST AIA-PACK BNP Assay"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K211199.

Device name: ST AIA-PACK BNP Assay. Applicant as listed: Tosoh Bioscience, Inc..

Decision date: 2021-11-08. Decision wording: Substantially Equivalent.

Product code: NBC. Regulation: 21 CFR 862.1117. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.